foxo4-dri senolytic peptide human trial 2024 regulates endothelial cell senescence via the P53 signaling pathway Cellular Aging and Senescence in
Description
Restore your bodys natural resilience
Despite this relatively short half-life in circulation, the downstream metabolic effects persist for significantly longer due to the sustained activation of lipolytic enzymes and metabolic pathways initiated by the peptide
Like Selank, it was also developed in Russia and is primarily used for its nootropic and neuroprotective effects
Although it is commonly associated with skin rejuvenation, researchers have also explored its potential role in recovery and inflammation support
A controlled study
